Abstract:Objective: The objective of this study was to explore the association between coronary artery disease and genetic polymorphisms of the renin–angiotensin–aldosterone system (RAAS) pathway. In addition, we examined the interactions between demographic and lifestyle risk factors (environmental factors including age, sex, smoking status, alcohol intake) and RAAS polymorphisms on disease risk. Methods: A total of 1089 subjects who underwent coronary angiography were enrolled in this study. Eight RAAS polymorphisms were genotyped in this population: the G2350A (rs4343) polymorphism in exon 17 of the angiotensin converting enzyme (ACE) gene, 1166A→C (rs5186) and 573C/T (rs5182) in the angiotensin II type 1 receptor (AGTR1) gene, the -344C→T transversion (rs1799998) in the aldosterone synthase (CYP11B2) gene, and the G-217A (rs5049), G-6A (rs5051), M235T (rs699; T4072C), and T174M (rs4762; C3889T) polymorphisms in the angiotensinogen (AGT) gene. Subjects with coronary heart disease were defined as those with at least 50% stenosis in at least one major coronary artery, and, the severity of coronary atherosclerosis was defined by the Gensini scoring system. Results: Compared to the subjects with AA genotype, the subjects with AG + GG genotype of rs1799998 had significant lower gensini score (p=0.029). After adjusting for age, gender, cigarette smoking, and alcohol intake status, the AG genotype (OR 0.717 95%CI 0.541–0.950, p=0.021) and the AG + GG genotype (OR 0.730 95%CI 0.559–0.954, p=0.021) distributions of rs1799998 were significantly different between the cases and controls compare to the AA genotype. Subjects with three at-risk loci had increased risk of coronary artery disease compared to subjects carrying 0 or 1 risk-associated polymorphism (OR [95% CI]:1.579 [1.077–2.316], p=0. 019), and the significance of the association was not reduced after adjusting for age, sex, cigarette smoking, or alcohol intake (adjusted OR [95% CI]: 1.673 [1.116–2.507], p=0.013). The results of multifactor-dimensionality reduction analysis revealed an interaction effect of CYP11B2 -344C→T, age, and smoking status on the risk of coronary heart disease (training OR [95% CI]: 3.7685 [2.8463–4.9895], p<0.0001; testing OR [95% CI]: 2.7583 [1.2038–6.3203], p=0.015). Conclusions: Subjects who carried the G allele of the rs1799998 polymorphism significantly associated with coronary heart disease and severity of coronary atherosclerosis estimated by the Gensini score in the whole population of the study. And, multiple RAAS gene polymorphisms are associated with coronary artery disease. The interaction of the CYP11B2 -344C→T polymorphism (rs1799998), age, and smoking status is also associated with enhanced risk of coronary artery disease.

Gene polymorphism of rennin-angiotensin system and in-stent restenosis after percutaneous transluminal coronary angioplasty plus stenting

Multiple predictors of in-stent restenosis after stent implantation in symptomatic intracranial atherosclerotic stenosis.

Relationship Between the Polymorphism of Angiotensin Ⅰ Converting Enzyme Gene and Instent Restenosis after PTCA with Stent Planting

Gene Polymorphisms of the Renin-Angiotensin-Aldosterone System as Risk Factors for the Development of In-Stent Restenosis in Patients with Stable Coronary Artery Disease

Association of ACE gene polymorphisms with in-stent restenosis by stent type (biomime, supraflex, xience)

Factors Influencing Stent Restenosis After Percutaneous Coronary Intervention in Patients with Coronary Heart Disease: A Clinical Trial Based on 1-Year Follow-Up

Investigation of factors related to the occurrence of in-stent restenosis after percutaneous coronary intervention

Incidence and risk factors of in-stent restenosis after percutaneous coronary intervention in patients from southern China

The Association Between Cyp2c19 Genotype and of In-Stent Restenosis among Patients with Vertebral Artery Stent Treatment

The Analysis of Risk Factors in the Case of Coronary Artery In-Stent Restenosis

Risk factors for in-stent restenosis after coronary stent implantation in patients with coronary artery disease: A retrospective observational study

Influential Factors of In-Stent Restenosis in Patients with Chronic Total Occlusion after Percutaneous Coronary Intervention

Long-Term Risk Factors for Intracranial In-Stent Restenosis from a Multicenter Trial of Stenting for Symptomatic Intracranial Artery Stenosis Registry in China

A Preliminary Study of Association Between the Polymorphism K469E of Intercellular Adhesion Molecule-1 Gene and Restenosis after Coronary Stenting

Identifying risk factors for in-stent restenosis in symptomatic intracranial atherosclerotic stenosis: a systematic review and meta-analysis

Joint effects of PPAR G-C161T (rs3856806) polymorphism and cardiovascular risk factors on restenosis risk after coronary stent implantation

THE INCIDENCE OF RENAL ARTERY STENOSIS IN THE PATIENTS WITH CHD TREATING WITH VARIOUS THERAPEUTIC REGIMENS

Polymorphism K469E of Intercellular Adhesion Molecule-1 Gene and Restenosis after Coronary Stenting in Chinese Patients.

Associations Between Polymorphisms of Endothelial Nitric Oxide Synthase, Matrix Metalloproteinase 3, Angiotensinogen, and Angiotensin II Type 1 Receptor and Risk of Restenosis after Percutaneous Coronary Intervention: A Meta-analysis

Increased glycated albumin and decreased esRAGE concentrations are associated with in-stent restenosis in Chinese diabetic patients.

Renin-Angiotensin-Aldosterone System Gene Polymorphisms and Coronary Artery Disease: Detection of Gene-Gene and Gene-Environment Interactions